These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 6636782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
    Rihmer Z, Arató M, Bagdy G.
    Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Report on efficacy of treatments for bipolar disorder.
    Gelenberg AJ, Hopkins HS.
    Psychopharmacol Bull; 1993 Jul; 29(4):447-56. PubMed ID: 8084977
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA, Post RM, Parekh PI, Worthington K.
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [Abstract] [Full Text] [Related]

  • 7. Phenomenology of rapid cycling manic depression and its treatment with valproate.
    Calabrese JR, Delucchi GA.
    J Clin Psychiatry; 1989 Mar; 50 Suppl():30-4. PubMed ID: 2494157
    [Abstract] [Full Text] [Related]

  • 8. Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature.
    Schöpf J.
    Pharmacopsychiatry; 1989 Sep; 22(5):174-82. PubMed ID: 2682691
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment and prevention of mania: lithium and alternatives].
    Vestergaard P.
    Ugeskr Laeger; 1993 Aug 09; 155(32):2438-42. PubMed ID: 8102824
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug 09; 14(78):140-2. PubMed ID: 16106596
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE, Kleindienst N, Evoniuk G, Bowden C, Möller HJ, Bohus M, Frangou S, Greil W, Calabrese JR.
    J Affect Disord; 2009 Jun 09; 115(3):466-70. PubMed ID: 19019453
    [Abstract] [Full Text] [Related]

  • 17. L-tryptophan in depression.
    Farkas T, Dunner DL, Fieve RR.
    Biol Psychiatry; 1976 Jun 09; 11(3):295-302. PubMed ID: 779855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bipolar depression: issues in diagnosis and treatment.
    Thase ME.
    Harv Rev Psychiatry; 2005 Jun 09; 13(5):257-71. PubMed ID: 16251165
    [Abstract] [Full Text] [Related]

  • 20. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A, Schmauss M.
    Nervenarzt; 1993 Jan 09; 64(1):70-2. PubMed ID: 8437650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.